Christopher L. Parks
23Patents
4h-index
32Co-inventors
63Inventor score
Filing activity: Oct 1, 2002 → May 16, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6664066B2 | Modified Morbillivirus V proteins | Chemistry; Metallurgy | 64 | Expired |
| US6673572B2 | Methods for rescue of RNA viruses | Chemistry; Metallurgy | 7 | Expired |
| US8647638B2 | Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US9347065B2 | Methods to improve vector expression and genetic stability | Chemistry; Metallurgy | 5 | Active |
| US10894080B2 | Transgenic VERO-CD4/CCR5 cell line | Chemistry; Metallurgy | 0 | Active |
| US10081796B2 | Neutralization-resistant CDV mutants and viral vectors | Chemistry; Metallurgy | 0 | Active |
| US9802986B2 | Recombinant viral vectors | Physics | 0 | Active |
| US10544430B2 | Vesicular stomatitis virus and virus rescue system | Chemistry; Metallurgy | 0 | Active |
| US9925258B2 | Replication-competent VSV-HIV Env vaccines | Chemistry; Metallurgy | 0 | Active |
| US9610346B2 | Recombinant viral vectors | Chemistry; Metallurgy | 0 | Active |
| US12311021B2 | Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins | Chemistry; Metallurgy | 0 | Active |
| US10202424B2 | Recombinant viral vectors | Physics | 0 | Active |
| US10844095B2 | Recombinant viral vectors | Physics | 0 | Active |
| US9944935B2 | Methods to improve vector expression and genetic stability | Chemistry; Metallurgy | 0 | Active |
| US11891416B2 | Recombinant viral vectors | Physics | 0 | Active |
| US10792357B2 | Optimized HIV envelope gene and expression thereof | Chemistry; Metallurgy | 0 | Active |
| US9562078B2 | Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutations | Chemistry; Metallurgy | 0 | Active |
| US10279027B2 | Transgenic Vero-CD4/CCR5 cell line | Chemistry; Metallurgy | 0 | Active |
| US9402894B2 | Viral particles derived from an enveloped virus | Chemistry; Metallurgy | 0 | Active |
| US12305190B2 | Vesicular stomatitis virus and virus rescue system | Chemistry; Metallurgy | 0 | Active |
| US8287878B2 | Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11667930B2 | Vesicular stomatitis virus and virus rescue system | Chemistry; Metallurgy | 0 | Active |
| US10220087B2 | Optimized HIV envelope gene and expression thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.